Aurinia Pharmaceuticals Inc. 10-Q filing
Filed 2025-11-04 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001600620-25-000106
- Form type
- 10-Q
- CIK
- 0001600620
- Primary document
- https://www.sec.gov/Archives/edgar/data/1600620/000160062025000106/auph-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aurinia Pharmaceuticals Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $205.9M | - | - |
| Cost Of Revenue | $23.9M | - | - |
| Operating Income | $71.7M | - | - |
| Net Income | $76.4M | - | - |
| Eps Basic | 0.57 | - | - |
| Eps Diluted | 0.55 | - | - |
| Cash And Equivalents | $72.9M | - | - |
| Total Assets | $527.5M | - | - |
| Total Liabilities | $161.8M | - | - |
| Shareholders Equity | $365.8M | - | - |
| Operating Cash Flow | $90.0M | - | - |